The “elimination” of the left atrial appendage (LAA) seems to be an attractive alternative to
oral anticoagulation in the treatment of atrial fibrillation, especially in patients with …

For many years, the left atrial appendage (LAA) was considered a dormant embryological
remnant; however, it is a structurally complex and functional organ that contributes to cardiac …

Elimination of the left atrial appendage (LAA) might be an attractive alternative to
anticoagulation since over 90% of thrombi occur within the LAA. However, before discussing …

Atrial fibrillation (AF) is the most common clinically relevant cardiac arrhythmia. AF poses
patients at increased risk of thromboembolism, in particular ischemic stroke. The CHADS2 …

Understanding the anatomy, physiology, and arrhythmogenic and thrombogenic roles of the
left atrial appendage (LAA) has become very important. The potential deleterious effects of …

Cardioembolism is the major cause of disability and death which can be clearly attributed to
atrial fibrillation (AF), particularly in the elderly [1–6]. Systemic anticoagulation with warfarin …

The atrial appendage (LAA) is a well-established source of cardioembolism in patients with
atrial fibrillation. Therefore, research involving the LAA has largely focused on its …

The left atrial appendage (LAA) is derived from the left wall of the primary atrium, which
forms during the fourth week of embryonic development. It has developmental …

The LAA is the remnant of the embryonic left atrium, whereas the smooth-walled left atrium
originates from the primordial pulmonary vein and its branches. The LAA is largely …

Known for the pathological connection to atrial fibrillation (AF), the left atrial appendage
(LAA) is the most common source of thromboembolism in patients with AF and may be an …